Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials We wish to caution the public that Glenmark does not collect any monies or any other valuables as a pre or post-employment requirement. Glenmark ’s pursuit of innovative drug discovery started over two decades ago with a vision to find cures for the unmet medical needs of patients across the globe by providing novel therapeutic options.
